• AI Risk Score on Screening Mammograms Preceding Breast Cancer Diagnosis 

      Larsen, Marthe; Olstad, Camilla Flåt; Koch, Henrik Wethe; Martiniussen, Marit Almenning; Hoff, Solveig Kristin Roth; Lund-Hanssen, Håkon; Solli, Helene; Mikalsen, Karl Øyvind; Auensen, Steinar; Nygård, Jan Franz; Lång, Kristina; Chen, Yan; Hofvind, Solveig Sand-Hanssen (Journal article; Tidsskriftartikkel; Peer reviewed, 2023-10-17)
      More than 38% of both screen-detected and interval cancers were assigned the highest artificial intelligence risk score on screening mammograms that preceded breast cancer diagnosis.<p> <p>Background - Few studies have evaluated the role of artificial intelligence (AI) in prior screening mammography.<p> <p>Purpose - To examine AI risk scores assigned to screening mammography in women who were ...
    • Norwegian radiologists’ expectations of artificial intelligence in mammographic screening – A cross-sectional survey 

      Martiniussen, Marit Almenning; Larsen, Marthe; Larsen, Anne Sofie Frøyshov; Hovda, Tone; Koch, Henrik Wethe; Bjørnerud, Atle; Hofvind, Solveig Sand-Hanssen (Journal article; Tidsskriftartikkel; Peer reviewed, 2023-08-23)
      Purpose: To explore Norwegian breast radiologists’ expectations of adding artificial intelligence (AI) in the interpretation procedure of screening mammograms.<p> <p>Methods: All breast radiologists involved in interpretation of screening mammograms in BreastScreen Norway during 2021 and 2022 (n = 98) were invited to take part in this anonymous cross-sectional survey about use of AI in mammographic ...
    • Screen-detected and interval breast cancer after concordant and discordant interpretations in a population based screening program using independent double reading 

      Martiniussen, Marit Almenning; Sagstad, Silje; Larsen, Marthe; Larsen, Anne Sofie Frøyshov; Hovda, Tone; Lee, Christoph I.; Hofvind, Solveig Sand-Hanssen (Journal article; Tidsskriftartikkel; Peer reviewed, 2022-04-02)
      Objectives - To analyze rates, odds ratios (OR), and characteristics of screen-detected and interval cancers after concordant and discordant initial interpretations and consensus in a population-based screening program.<p> <p>Methods - Data were extracted from the Cancer Registry of Norway for 487,118 women who participated in BreastScreen Norway, 2006–2017, with 2 years of follow-up. All mammograms ...